Showing results (81-90 of 232) with videos related to
Sort By:
Pageof 24
The American Journal of Psychiatry|December 1, 1993
Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzineJ R Cornelius, P H Soloff, J M Perel, et al.Psychopharmacology Bulletin|January 1, 1997
Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newbornsK L Wisner, J M Perel, R L Findling, et al.Psychopharmacology Bulletin|January 1, 1990
Fluoxetine trial in borderline personality disorderJ R Cornelius, P H Soloff, J M Perel, et al.Psychopharmacology Bulletin|January 1, 1996
Paroxetine is a novel nitric oxide synthase inhibitorM S Finkel, F Laghrissi-Thode, B G Pollock, et al.The Journal of Clinical Psychiatry|October 8, 1999
Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 yearsG Walters, C F Reynolds, B H Mulsant, et al.Therapeutic Drug Monitoring|October 1, 1996
Bupropion plasma levels and CYP2D6 phenotypeB G Pollock, R A Sweet, M Kirshner, et al.Clinical Pharmacology and Therapeutics|September 19, 2009
Predicting age-specific dosing of antipsychoticsH Uchida, B G Pollock, R R Bies, et al.Journal of Clinical Psychopharmacology|February 1, 1990
Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophreniaE M Kahn, S C Schulz, J M Perel, et al.Journal of Chromatography|November 12, 1982
Gas chromatographic analysis of ketamine and norketamine in plasma and urine: nitrogen-sensitive detectionR L Stiller, P G Dayton, J M Perel, et al.Journal of Clinical Psychopharmacology|April 1, 1991
A preliminary trial of fluoxetine in refractory borderline patientsJ R Cornelius, P H Soloff, J M Perel, et al.Pageof 24